Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
13.48
+0.52 (4.01%)
At close: Feb 6, 2026, 4:00 PM EST
13.47
-0.01 (-0.07%)
After-hours: Feb 6, 2026, 4:16 PM EST
Arvinas Market Cap
Arvinas has a market cap or net worth of $865.74 million as of February 6, 2026. Its market cap has decreased by -30.85% in one year.
Market Cap
865.74M
Enterprise Value
86.80M
1-Year Change
-30.85%
Ranking
Category
Stock Price
$13.48
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $865.74M, an increase of 67.73%. That is a compound annual growth rate of 7.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 832.35M | 9.27% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 950.27M |
| Palvella Therapeutics | 945.85M |
| UroGen Pharma | 936.18M |
| ArriVent BioPharma | 934.40M |
| Bicara Therapeutics | 931.84M |
| Xencor | 856.21M |
| Omeros | 838.04M |
| Maravai LifeSciences Holdings | 833.60M |